ACUTE/SUBACUTE METABOLIC & HEMODYNAMIC TRAUMATIC BRAIN INJURY DETERMINANTS
ACUTE/SUBACUTE METABOLIC & HEMODYNAMIC TRAUMATIC BRAIN INJURY DETERMINANTS
批准号:
6320870
负责人:
MYRON DAVID GINSBERG
金额:
$20.74万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-06-01 至 2001-05-31
关键词:
NMDA receptors brain circulation brain injury brain metabolism disease /disorder model endothelin free radical oxygen free radical scavengers glial fibrillary acidic protein glucose metabolism immunocytochemistry in situ hybridization induced hypothermia laboratory rat microdialysis nitric oxide regulatory gene trauma
中文摘要
我们建议详细调查本地和本地之间的关系
急性和慢性脑出血患者脑糖代谢和血流量的变化
大脑皮质液压冲击伤(FPI)后的亚急性期
老鼠。使用新的3D放射自显影图像获得令人兴奋的飞行员数据-
我们开发的平均策略揭示了显着的新陈代谢>;
FPI后急性期的流动去耦合,我们认为这强加于
对组织造成严重的新陈代谢压力。相比之下,充血是
观察时间为五天。使用匹配的动物群体和差异
分析算法,我们将全面描述ICBF、ICMRgl
以及FPI后前五天的ICMRgl/ICBF比率。我们
假设脱钩在最初的几个小时内持续,但
1-2天后汇款。接下来,我们将确定这些扰动是如何
受创伤后治疗低温的影响,给予
要么提早(前3小时)。或启动时间稍晚(3-5小时)
精神创伤。我们假设治疗性低温逆转脱偶联
从而保护组织。我们将确定该组织的角色
创伤后ICBF中的一氧化氮/一氧化氮合酶系统
改变,要么是通过急剧减少的血管NO产生,要么是通过
后期诱导型一氧化氮合酶的表达。这将通过现场研究
杂交、免疫组织化学和酶活性分析,
再加上对创伤性大脑中循环GMP产生的评估。
内皮素和/或5-羟色胺是下列ICBF的潜在调节剂
创伤,这些也将通过脑内微透析和
使用特定的药理拮抗剂。最后,我们打算
更全面地描述本地化证据之间的关系
代谢应激(新陈代谢和解偶联)和临时性和
基因表达的空间特征:我们将集中在hsp70,
即刻早期基因、胶质纤维酸性蛋白和
神经营养因子,脑源性神经营养因子。我们的试点数据,在每个
例如,已经揭示了与创伤相关的基因表达变化。这个
这些基因表达模式与细胞凋亡的关系将是
评估过了。最后,我们将调查具体的影响
治疗干预,包括NMDA和非NMDA拮抗,以及
氧自由基清除、CMRg1/CBF相互关系及
基因表达。这些研究将提供一个全面的概述
急性期和亚急性期的血流动力学和代谢。
英文摘要
We propose to investigate in detail the interrelationships between local
brain glucose metabolism (ICMRgl) and blood flow (ICBF) in the acute and
subacute periods following cortical fluid-percussion injury (FPI) in the
rat. Exciting pilot data obtained using novel 3D autoradiographic image-
averaging strategies developed by us have disclosed marked metabolism >
flow uncoupling in the acute period after FPI, which we believe imposes
a severe metabolic stress upon the tissue. In contrast, hyperemia was
observed at five days. Using matched animal groups and the disparity
analysis algorithm, we shall comprehensively characterize ICBF, ICMRgl
and the ICMRgl/ICBF ratio over the first five days following FPI. We
hypothesize that uncoupling persists during the first few hours but
remits after 1-2 days. Next, we shall ascertain how these perturbations
are influenced by post-traumatic therapeutic hypothermia, administered
either early (first 3 h). or initiated somewhat later (3-5 h) following
trauma. We hypothesize that therapeutic hypothermia reverse uncoupling
and thereby protects the tissue. We shall establish the role of the
nitric oxide/nitric oxide synthase (NOS) system in post-traumatic ICBF
changes, either via diminished vascular NO production acutely or by
expression of iNOS at later time. This will be studied via in situ
hybridization, immunohistochemistry, and enzymatic activity assays,
coupled with assessment of cyclic GMP production in the traumatic brain.
As endothelin and/or serotonin are potential modulators of ICBF following
trauma, these will also be assessed via intracerebral microdialysis and
the use of specific pharmacologic anatagonists. Finally, we intend to
characterize more fully the relationship between the localized evidence
of metabolic stress (metabolism > uncoupling) and the temporal and
spatial features of gene expression: we shall concentrate on hsp7O,
immediate early genes, glial fibrillary acidic protein, and the
neurotrophin, brain- derived neurotrophic factor. Our pilot data, in each
instance, have revealed trauma-related changes in gene expression. The
relationship of these patterns of gene expression to apoptosis will be
assessed. Finally, we shall investigate the effect of specific
therapeutic interventions, including NMDA and non-NMDA antagonism, and
the scavenging of oxygen radicals, on CMRgl/CBF interrelationships and
gene expression. These studies will provide a comprehensive overview of
hemodynamics and metabolism in the acute and subacute periods.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ALIAS II/III Trial:Albumin Therapy in Ischemic Stroke
-
批准号:6796049
-
项目类别:
-
资助金额:$20.41万
-
财政年份:2004
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
SHARED CONFOCAL MICROSCOPY FACILITY
-
批准号:6577453
-
项目类别:
-
资助金额:$29.47万
-
财政年份:2003
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
Azulenyl nitrones: neuroprotectants in stroke and trauma
-
批准号:7064212
-
项目类别:
-
资助金额:$58.86万
-
财政年份:2003
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
Azulenyl nitrones: neuroprotectants in stroke and trauma
-
批准号:6669554
-
项目类别:
-
资助金额:$57.35万
-
财政年份:2003
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
Azulenyl nitrones: neuroprotectants in stroke and trauma
-
批准号:6744834
-
项目类别:
-
资助金额:$56.85万
-
财政年份:2003
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
Azulenyl nitrones: neuroprotectants in stroke and trauma
-
批准号:6877742
-
项目类别:
-
资助金额:$58.54万
-
财政年份:2003
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
HUMAN ALBUMIN THERAPY OF ACUTE ISCHEMIC STROKE
-
批准号:6326306
-
项目类别:
-
资助金额:$51.2万
-
财政年份:2001
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
HUMAN ALBUMIN THERAPY-TREATMENT OF ACUTE ISCHEMIC STROKE
-
批准号:6650873
-
项目类别:
-
资助金额:$53.18万
-
财政年份:2001
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
ACUTE/SUBACUTE METABOLIC & HEMODYNAMIC TRAUMATIC BRAIN INJURY DETERMINANTS
-
批准号:6455813
-
项目类别:
-
资助金额:$23.88万
-
财政年份:2001
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
HUMAN ALBUMIN THERAPY OF ACUTE ISCHEMIC STROKE
-
批准号:6579862
-
项目类别:
-
资助金额:$0.76万
-
财政年份:2001
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
HUMAN ALBUMIN THERAPY-TREATMENT OF ACUTE ISCHEMIC STROKE
-
批准号:6529473
-
项目类别:
-
资助金额:$52.33万
-
财政年份:2001
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
ALIAS Phase lll Trial Albumin in Acute Ischemic Stroke
-
批准号:7261865
-
项目类别:
-
资助金额:$590.92万
-
财政年份:2000
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
ALIAS Phase IIi Multicenter Clincal Trial -- Albumin in Acute Ischemic Stroke
-
批准号:8105711
-
项目类别:
-
资助金额:$461.7万
-
财政年份:2000
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
ALIAS Phase lll Trial Albumin in Acute Ischemic Stroke
-
批准号:6969095
-
项目类别:
-
资助金额:$285.57万
-
财政年份:2000
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
ALIAS Phase lll Trial Albumin in Acute Ischemic Stroke
-
批准号:7498524
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2000
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
ALIAS Phase lll Trial Albumin in Acute Ischemic Stroke
-
批准号:7623196
-
项目类别:
-
资助金额:$318.88万
-
财政年份:2000
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
CORE--SCIENTIFIC
-
批准号:6111984
-
项目类别:
-
资助金额:$15.29万
-
财政年份:1999
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
ACUTE/SUBACUTE METABOLIC & HEMODYNAMIC TRAUMATIC BRAIN INJURY DETERMINANTS
-
批准号:6205036
-
项目类别:
-
资助金额:$20.74万
-
财政年份:1999
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
CORE--COMPUTING AND IMAGE-PROCESSING
-
批准号:6111985
-
项目类别:
-
资助金额:$15.29万
-
财政年份:1999
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
FOCAL CEREBRAL ISCHEMIA--PATHOPHYSIOLOGY, ACUTE THERAPY, RECOVERY OF FUNCTION
-
批准号:6111981
-
项目类别:
-
资助金额:$15.29万
-
财政年份:1999
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
海外基金